Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of stock option activity under our equity plans

A summary of stock option activity under our equity plans for the three months ended March 31, 2022 follows:





Number of Options

 



Weighted Average Exercise Price

 



Weighted Average Remaining Contractual Term (Years)

 



Aggregate Intrinsic Value

 

Balance, December 31, 2021

 

 

10,589,010

 

 

$

14.85

 

 

 

7.39

 

 

$

22,473,835

 

Granted

 

 

688,240

 

 

 

3.96

 

 

 

 

 

 

 

Exercised

 

 

(50,000

)

 

 

3.28

 

 

 

 

 

 

81,300

 

Balance, March 31, 2022



 

11,227,250

 



 

14.24

 

 

 

7.32

 

 

 

11,642,645

 

Exercisable



 

4,357,385

 

 

$

4.78

 

 

 

4.96

 

 

$

10,334,662

 

Vested and expected to vest



 

11,227,250

 

 

$

14.24

 

 

 

7.32

 

 

$

11,642,645

 

Schedule of share based compensation activity

The following table sets forth the allocation of our stock-based compensation expense.

 

 

Three Months Ended March 31,

 

(in thousands)

 

2022

 

 

2021

 

Cost of revenue

 

$

29

 

 

$

26

 

Selling, general and administrative

 

 

11,866

 

 

 

5,780

 

Research and development

 

 

1,805

 

 

 

859

 

Total stock-based compensation

 

$

13,700

 

 

$

6,665